Assenagon Asset Management S.A. Eli Lilly & CO Transaction History
Assenagon Asset Management S.A.
- $60.5 Billion
- Q2 2025
A detailed history of Assenagon Asset Management S.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,481,031 shares of LLY stock, worth $1.08 Billion. This represents 1.91% of its overall portfolio holdings.
Number of Shares
1,481,031
Previous 716,021
106.84%
Holding current value
$1.08 Billion
Previous $591 Million
95.23%
% of portfolio
1.91%
Previous 1.08%
Shares
29 transactions
Others Institutions Holding LLY
# of Institutions
4,445Shares Held
781MCall Options Held
16.5MPut Options Held
12.2M-
Lilly Endowment Inc Indianapolis, IN96MShares$70.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$58.9 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$48.2 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$37.6 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$25.3 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $696B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...